Showing 1331-1340 of 1633 results for "".
- American Women Account for Majority of Cosmetic Procedures Done in Tijuanahttps://modernaesthetics.com/news/american-women-account-for-majority-of-cosmetic-procedures-done-in-tijuana/2473583/A recent report from the Border Report states women from the United States and Canada account for majority of the cosmetic procedures done in Tijuana, Mexico.&nbs
- Sustainable Skincare Dispenser Introducedhttps://modernaesthetics.com/news/sustainable-skincare-dispenser-introduced/2473582/LyondellBasell has collaborated with Coradin and Dermalogica to create a dispenser for skincare and other products that is composed of more than 75% recycled material, according to a press release. The Greenis® Dispenser leverages LyondellBasell’s CirculenRecover polypropylene
- Study: Botox Can Identify Migraine Trigger Siteshttps://modernaesthetics.com/news/study-botox-can-identify-migraine-trigger-sites/2473575/Botulinum toxin type A (Botox) injections could be useful in nerve decompression migraine surgery, according to a study in Plastic and Reconstructive Surgery. “Diagnostic targeted Botox injections have a very high positive predictive value,” the authors write. “It is t
- YoungMD Connect Review: Tell-All Tribunehttps://modernaesthetics.com/news/youngmd-connect-review-tell-all-tribune/2473573/The Tell-All Tribune aesthetic think tank in Fort Lauderdale, Florida, in April emerged as a groundbreaking collaborative conference, providing a platform where thought leaders in aesthetics converged to shape the future of the field. Under the leadership of course director Shino Bay Aguilera, DO
- Botulism-Like Symptoms Linked to Suspected Fake Cosmetic Injections in Illinoishttps://modernaesthetics.com/news/botulism-like-symptoms-linked-to-suspected-fake-cosmetic-injections-in-illinois/2473557/The Illinois Department of Public Health (IDPH) has issued a warning to healthcare facilities, particularly hospital ERs, urging heightened vigilance for patients exhibiting symptoms resembling botulism. The advisory follows the identification of a clus
- Allergan Aesthetics Launches Program to Elevate the Conversation Around Ethics in Aestheticshttps://modernaesthetics.com/news/allergan-aesthetics-launches-program-to-elevate-the-conversation-around-ethics-in-aesthetics/2473556/Allergan Aesthetics announced the launch of 'Moving the Needle on Ethics,' a collaboration with medical aesthetics experts from around the globe aimed at elevating discussions on ethics in aesthetics. The collection of interviews is designed to highlight the
- FDA Approves Juvederm Voluma XC for Temple Hollowinghttps://modernaesthetics.com/news/fda-approves-juvederm-voluma-xc-for-temple-hollowing/2473553/Allergan Aesthetics has received FDA approval of Juvederm Voluma XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.[1] The injection is the first and only hyaluronic acid (HA) dermal filler to receive FDA approval
- Kenvue to Showcase 22 New Sets of Clinical Data at AADhttps://modernaesthetics.com/news/kenvue-to-showcase-22-new-sets-of-clinical-data-at-aad/2473552/Kenvue announced it will share 22 data sets detailing new Kenvue skin science research at the American Academy of Dermatology (AAD) Association annual meeting, March 8-12, in San Diego. Evidence will be presented on the clinical effectiveness of Neutrogena and Aveeno
- Trufacial Touts Survey Showing High Satisfaction with Facial Rejuvenation Systemhttps://modernaesthetics.com/news/trufacial-survery-results/2473550/A market survey of 100 female consumers revealed that 100% of participants found the skin-perfecting TrufacialTM hand-held device not only met their skincare needs, but also exceeded expectations after only
- Cutera Launches AviClear for the Treatment of Acne in UK, Europe and Australiahttps://modernaesthetics.com/news/cutera-launches-aviclear-for-the-treatment-of-acne-in-uk-europe-and-australia/2473548/Cutera announced the international limited commercial release of AviClear, which the company describes as the first energy-based device FDA-cleared for the long-term treatment of mild, moderate, and severe acne. AviClear is now commercially available, on a limited basis, in the UK, Europe, a